Literature DB >> 19320603

A decrease in albumin in early SIV infection is related to viral pathogenicity.

Susan M Graham1, Sarah Holte, Jason T Kimata, Mark H Wener, Julie Overbaugh.   

Abstract

A decrease in circulating albumin levels after seroconversion has been reported as a predictor of disease progression in HIV-infected adults. We hypothesized that a similar decrease would be seen in pig-tailed macaques in early SIV infection, and that the degree of this decrease would be related to the pathogenicity of the infecting viral strain. Ten juvenile pig-tailed macaques were previously inoculated with virus derived from molecular clones representing different stages of infection: early (SIVMneCL8, n = 2), intermediate (SIVMne35wkSU, n = 2), late blood (SIVMne170, n = 3), or late lymph node (SIVMne027, n = 3). Albumin was measured in stored samples. Changes from baseline were evaluated by paired sample t tests and by linear regression with generalized estimating equations (GEE). Albumin levels decreased in the week after SIV inoculation (p = 0.02), increased above baseline at week 5, then fell, returning below baseline by week 16 (p = 0.03). In GEE modeling, albumin decreased significantly in both early and chronic infection (weeks 0-3, p < 0.001; weeks 5-16, p = 0.004) and this change differed significantly between infections caused by late versus early or intermediate virus variants (weeks 0-3, p = 0.002; weeks 5-16, p = 0.001). A decrease in albumin levels occurs in both early and chronic SIV infection, and is more marked in macaques infected with more pathogenic virus variants. These results suggest that both early and late events in SIV pathogenesis are influenced by properties of the infecting viral strain.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19320603      PMCID: PMC2768648          DOI: 10.1089/aid.2008.0267

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  47 in total

1.  The influence of nutritional and metabolic status on progression from asymptomatic HIV infection to AIDS-defining diagnosis.

Authors:  D Sharpstone; C Murray; H Ross; M Phelan; R Crane; A C Lepri; M Nelson; B Gazzard
Journal:  AIDS       Date:  1999-07-09       Impact factor: 4.177

2.  Emerging cytopathic and antigenic simian immunodeficiency virus variants influence AIDS progression.

Authors:  J T Kimata; L Kuller; D B Anderson; P Dailey; J Overbaugh
Journal:  Nat Med       Date:  1999-05       Impact factor: 53.440

Review 3.  HIV infection and the gastrointestinal tract.

Authors:  Donald P Kotler
Journal:  AIDS       Date:  2005-01-28       Impact factor: 4.177

Review 4.  Acute-phase proteins and other systemic responses to inflammation.

Authors:  C Gabay; I Kushner
Journal:  N Engl J Med       Date:  1999-02-11       Impact factor: 91.245

5.  Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection.

Authors:  Joseph J Mattapallil; Daniel C Douek; Brenna Hill; Yoshiaki Nishimura; Malcolm Martin; Mario Roederer
Journal:  Nature       Date:  2005-04-28       Impact factor: 49.962

6.  Early antiretroviral therapy for simian immunodeficiency virus infection leads to mucosal CD4+ T-cell restoration and enhanced gene expression regulating mucosal repair and regeneration.

Authors:  Michael D George; Elizabeth Reay; Sumathi Sankaran; Satya Dandekar
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

7.  A lymph node-derived cytopathic simian immunodeficiency virus Mne variant replicates in nonstimulated peripheral blood mononuclear cells.

Authors:  J T Kimata; A Mozaffarian; J Overbaugh
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

8.  Changes in the extracellular envelope glycoprotein of variants that evolve during the course of simian immunodeficiency virus SIVMne infection affect neutralizing antibody recognition, syncytium formation, and macrophage tropism but not replication, cytopathicity, or CCR-5 coreceptor recognition.

Authors:  L M Rudensey; J T Kimata; E M Long; B Chackerian; J Overbaugh
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

Review 9.  HIV-associated nephropathy is a late, not early, manifestation of HIV-1 infection.

Authors:  J A Winston; M E Klotman; P E Klotman
Journal:  Kidney Int       Date:  1999-03       Impact factor: 10.612

10.  Insufficient production and tissue delivery of CD4+ memory T cells in rapidly progressive simian immunodeficiency virus infection.

Authors:  Louis J Picker; Shoko I Hagen; Richard Lum; Edward F Reed-Inderbitzin; Lyn M Daly; Andrew W Sylwester; Joshua M Walker; Don C Siess; Michael Piatak; Chenxi Wang; David B Allison; Vernon C Maino; Jeffrey D Lifson; Toshiaki Kodama; Michael K Axthelm
Journal:  J Exp Med       Date:  2004-11-15       Impact factor: 14.307

View more
  2 in total

1.  Depo-Provera does not alter disease progression in SIVmac-infected female Chinese rhesus macaques.

Authors:  Brigitte Sanders-Beer; Tahar Babas; Keith Mansfield; Dawn Golightly; Joshua Kramer; Abigail Bowlsbey; Debora Sites; Lourdes Nieves-Duran; Shuling Lin; Sherry Rippeon; Ginger Donnelly; Lowrey Rhodes; Yvette Edghill Spano
Journal:  AIDS Res Hum Retroviruses       Date:  2010-04       Impact factor: 2.205

2.  Successful isolation of infectious and high titer human monocyte-derived HIV-1 from two subjects with discontinued therapy.

Authors:  Tong Wang; Younong Xu; Haiying Zhu; Thomas Andrus; Sergei B Ivanov; Charlotte Pan; Jazel Dolores; Gregory C Dann; Michael Zhou; Dominic Forte; Zihuan Yang; Sarah Holte; Lawrence Corey; Tuofu Zhu
Journal:  PLoS One       Date:  2013-05-31       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.